Clinical Trial Update: Assessment of Adebelizumab Combined with Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluates Adebelizumab in combination with chemotherapy, with concurrent versus sequential radiotherapy as first-line treatment for ext…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Adebelizumab (Adebelizumab)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: SCLC, Extensive Stage, Immunotherapy | Phase 2 | Status: NOT_YET_RECRUITING